BIOT

featured image of Major Breakthrough: TRACT's TregCel™ Tech Moves to Taiwan!

Major Breakthrough: TRACT’s TregCel™ Tech Moves to Taiwan!

BIOT

🚀 TRACT Therapeutics transfers TregCel™ technology to Taiwan Bio! 🌟 Aiming to boost kidney transplant outcomes and patient quality of life. 🧬📈

featured image of Andelyn Biosciences Boosts Gene Therapy Efficiency!

Andelyn Biosciences Boosts Gene Therapy Efficiency!

BIOT

Andelyn Biosciences boosts AAV Curator™ platform with MyoAAV plasmids! 🚀 Enhancing gene therapy for muscles while reducing costs. 💪💰

featured image of Boosting Africa's Vaccines: $12B Tech Initiative!

Boosting Africa’s Vaccines: $12B Tech Initiative!

BIOT

🌍 Gavi's $1.2 billion initiative boosts Africa's vaccine production with innovative tech! 💉 Incentives for mRNA platforms prepare for future pandemics. 🤝

featured image of Revolutionizing Peptide Drugs: Sustainable Solutions Ahead!

Revolutionizing Peptide Drugs: Sustainable Solutions Ahead!

BIOT

🌱 Discover how we can make peptide-drug production more sustainable! 🔬 Explore greener biosynthesis methods for a healthier future! 🚀

featured image of Regeneron Cuts Costs by Streamlining AAV Production!

Regeneron Cuts Costs by Streamlining AAV Production!

BIOT

**Excerpt:** Regeneron revolutionizes AAV manufacturing by eliminating endonuclease! 🌟 Save up to $100,000 per batch while enhancing efficiency! 💰🔬⚙️

featured image of Revolutionizing Cell-Line Development for Faster Pandemics!

Revolutionizing Cell-Line Development for Faster Pandemics!

BIOT

🚀 U.S. researchers are revolutionizing cell-line development with automation, improving pandemic response timelines and enhancing antibody production! 🔬✨ Biotech

featured image of Sana Biotechnology Launches New Facility in WA!

Sana Biotechnology Launches New Facility in WA!

BIOT

Sana Biotechnology celebrates a new biomanufacturing facility in Bothell, WA, boosting cell and gene therapy production! 🎉🏭🧑‍🔬📦🤝

featured image of MilliporeSigma Boosts Gene Therapy with $600M Acquisition!

MilliporeSigma Boosts Gene Therapy with $600M Acquisition!

BIOT

MilliporeSigma acquires Mirus Bio for $600 million, boosting viral vector manufacturing and supporting gene therapy advancements! 🚀🔬💡🤝

featured image of Unlocking Sustainable Solutions: The Future of Synthetic Biology

Unlocking Sustainable Solutions: The Future of Synthetic Biology

BIOT

🌱 Discover how synthetic biology scales production, enhances sustainability, and fosters collaboration to tackle global challenges! 🤝🔬 SyntheticBiology Innovation

featured image of Urgent Need for Enhanced Biosafety Testing Now!

Urgent Need for Enhanced Biosafety Testing Now!

BIOT

**Excerpt:** 🌍 The time is now for enhanced biosafety testing! 🔬 Protect patient health with effective mycoplasma and virus testing in biologics. 🧪✨